Skip to main content
Pfizer COVID-19 vaccine appointments are available to our patients.
Sign up for Connect today
to schedule your vaccination.
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Joint Clinical Trials Office
Explore this Website
Home
About
Toggle About menu options
News
JCTO Contacts
Careers
Our Clinical Trial Locations
Partner with the JCTO
Toggle Partner with the JCTO menu options
JCTO Fees
Open Clinical Trials
Investigators
Patients
Toggle Patients menu options
What is a Clinical Trial?
Frequently Asked Questions
Clinical Trial Questions to Ask Your Healthcare Team
Clinical Trials: Common Terms to Know
Understanding Clinical Trials and How They Work
Understanding Clinical Trials - In Spanish | En Español
Weill Cornell Medicine
Care
Discover
Teach
Home
About
Open Clinical Trials
Investigators
Patients
Home
Clinical Trials
The Impact of Nutrient Sequence on Glycemic Excursions in Type 2 Diabetes Assessed by Continuous Glucose Monitoring
Study Status:
Open to Enrollment
Primary Investigator:
Date:
October 26, 2021
A Randomized Phase 3 Trial of Nivolumab in Combination with Chemo-immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-cell Lymphoma
Study Status:
Open to Enrollment
Primary Investigator:
Date:
October 26, 2021
A Phase 1/2 Open-Label, Multicenter Study of INCB000928 Administered as a Monotherapy or in Combination with Ruxolitinib in Participants with Anemia Due to Myeloproliferative Disorders
Study Status:
Open to Enrollment
Primary Investigator:
Date:
November 24, 2021
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure (ACLF): iNdications and outComEs (CHANCE Study)
Study Status:
Open to Enrollment
Primary Investigator:
Date:
December 14, 2021
A Phase 2 Trial of Paxalisib Combined with a Ketogenic Diet and Metformin for Newly Diagnosed and Recurrent Glioblastoma
Study Status:
Open to Enrollment
Primary Investigator:
Date:
January 11, 2022
Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer
Study Status:
Open to Enrollment
Primary Investigator:
Date:
March 18, 2022
A Phase II Study to Test the Efficacy of AB928 (Dual Adenosine Receptor Antagonist) and AB122 (a PD1 Checkpoint Inhibitor) in Combination With Short Course Radiotherapy and Consolidation Chemotherapy for Rectal Cancer (PANTHER)
Study Status:
Open to Enrollment
Primary Investigator:
Date:
March 18, 2022
A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide, and Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab
Study Status:
Open to Enrollment
Primary Investigator:
Date:
April 18, 2022
An Open Label, Phase 1, Treatment Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of IDE397 (MAT2A Inhibitor) In Adult Participants with Advanced Solid Tumors
Study Status:
Open to Enrollment
Primary Investigator:
Date:
April 25, 2022
A Phase 1b/2 Study of IMGN632 as Monotherapy or Combination with Venetoclax and/or Azacitidine for Patients with CD123-Positive Acute Myeloid Leukemia
Study Status:
Open to Enrollment
Primary Investigator:
Date:
May 3, 2022
« first
‹ previous
…
5
6
7
8
9
(current)
10
11
12
13
…
next ›
last »